Therefore, it is reasonable to infer that in tumors with lymph node metastasis, owing to the reduced or absent VDR expression, although with a high level of 1,25(OH)2D, they cannot sufficiently bind to VDR and exert its anti-tumor effects. The gene discussed is VDR; the disease is metastatic malignant neoplasm in the lymph nodes.